NEWSROOM

PRISM MarketView

SKYX Announces First Quarter 2024 Corporate Update Call

May 9, 2024

Company to Present First Quarter 2024 Financial Results; Conference Call to be held on Tuesday, May 14 at 4:30 p.m. Eastern Time MIAMI, FL, May 09, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 90 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that it will host a corporate update...

American Shared Hospital Services Announces Closing of Acquisition of 60% Majority Interest in Three Radiation Therapy Cancer Centers in Rhode Island

May 9, 2024

- Adds $9-$10 million in Annual Revenue with Positive Net Income Contribution - - Acquisition more than Doubles Backlog to over $210 million - - Expands U.S. Footprint and Product Offering - SAN FRANCISCO, CA, May 9, 2024—American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced the closing of its acquisition of a...

Mass Megawatts Announces a Cost Reduction Program for Low Income Households

May 8, 2024

WORCESTER, MA, May 08, 2024 – Mass Megawatts (OTC: MMMW) announces the availability of a new opportunity for generating revenue in this fiscal quarter that can help reduce the energy cost of low-income and disadvantaged households by more than 20 percent. The projects using the patent pending solar tracker and the recent global solar panel cost reductions can bring a great investment payback of three to five years depending on the size of the project in Massachusetts. More information on the...

Potencial de desarrollo de la Industria del Litio

May 7, 2024

New York City, 7 de mayo de 2024 Potencial de desarrollo de la Industria del Litio Obtenga el nuevo informe sin costo El equipo de Vostock Capital ha preparado un informe basado en una encuesta realizada a los +400 participantes en el Congreso Litio America latina 2023, entre los participantes encuestados: personal de los ministerios de minas y energías de América Latina, periodistas de minería, altos ejecutivos de las empresas mineras de Litio, gerentes de las empresas proveedoras de la...

Development Potential of the Lithium Industry

May 7, 2024

New York City, May 07, 2024 Development Potential of the Lithium Industry Get the new report for free The Vostock Capital team has prepared a report based on a survey carried out at the Lithium Latin America 2023 Congress about the development potential of the lithium industry. The survey was conducted among governmental authorities, leading industry companies, mining association presidents, mining journalists, and industry providers, which will cover: LATAM countries with the most favorable...

SKYX to be a Main Event at TheRealDeal New York City Real-Estate Forum & Developer Showcase

May 7, 2024

As SKYX Continues to Enhance its Market Penetration in the US and Canada it Will Showcase its Patented Game-Changing Smart Home Platform Technologies with High-End Real-Estate Developers and Industry Professionals MIAMI, FL, May 07, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), (the "Company" or "SKYX"), a highly disruptive platform technology company with over 90 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and...

BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

May 7, 2024

Conference Call on Tuesday, May 14th, at 4:30 pm ET POMPANO BEACH, FLORIDA, May 7, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading biotechnology company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, announced today that it plans to release its first quarter 2024 financial results post-market on Tuesday, May 14, 2024. BioStem will host a conference call and webcast at 4:30 pm ET on Tuesday, May 14, 2024. The call...

American Shared Hospital Services Announces First Quarter 2024 Earnings Conference Call

May 7, 2024

SAN FRANCISCO, CA, May 7, 2024—American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its first quarter 2024 financial results on Tuesday, May 14th at 4:30 pm ET / 1:30 pm PT. The first quarter 2024 financial results press release will be issued at the market close on...

BioStem Technologies Granted Prioritized Examination for Wound Healing Patent

May 6, 2024

POMPANO BEACH, FLORIDA, May 6, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, today announced that the United States Patent and Trademark Office (USPTO) has granted the Company’s request for Prioritized Examination for its application for U.S. Patent 18/290,914 titled STERILE HUMAN PLACENTAL ALLOGRAFTS AND METHODS OF MAKING THEREOF. “As we...

PRISM Q&A CORNER – Ashlee Vogenthaler , Markets Editor, PRISM MarketView

May 1, 2024

Decoding Market Dynamics: An Interview with Ashlee Vogenthaler, PRISM MarketView’s Markets Editor New York, May 01, 2024 - At PRISM MarketView we are proud to feature Ashlee Vogenthaler as our Markets Editor. Ashlee combines a deep understanding of finance and economics with a passion for writing, offering our readers insightful analyses and engaging commentary. Influenced early on by her mother’s finance career and an inspiring high school class, Ashlee developed a keen interest in the stock...

SIPP Industries Announces Strategic Acquisition of Revenue Share in Calypso Pharmaceuticals to Bolster Position in Cannabis and Hemp Industries

May 1, 2024

COSTA MESA, CA, May 01, 2024 – Sipp Industries, Inc. (OTC: SIPC), a leading player in the cannabis and hemp industries, announces its strategic acquisition of revenue share in Calypso Pharmaceuticals, a Texas-based company renowned for its innovative products and proprietary technology in the cannabis and hemp sectors. The acquisition marks a significant milestone in SIPP Industries' mission to expand its product portfolio and market presence.Calypso Pharmaceuticals specializes in developing...

Wanderport Corporation Announces New Joint Venture to Expand Global Markets for Clean Tech and Renewable Coconut Charcoal Products

Apr 30, 2024

SANTA MONICA, CA, April 30, 2024 – Wanderport Corporation (OTC: WDRP), a holding company, with a focus on energy, clean tech, and health tech is excited to announce a strategic joint venture aimed at expanding the coconut charcoal business worldwide. This venture, in partnership with the principal of Vietnam based Highland BP., Ltd, signifies a major step forward in the utilization of sustainable and eco-friendly fuel alternatives.The parties have executed the Letter of Intent and aim to...

BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts

Apr 30, 2024

POMPANO BEACH, FLORIDA, April 30, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived tissue allografts for advanced wound care, today announced that it has retained the services of Mr. Nick McCoy, who will lead BioStem’s Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU) clinical trials process as a consultant to the Company. BioStem’s clinical focus on completing these...

PRISM MarketView – Weekly Market Report – April 26, 2024

Apr 26, 2024

PRISM Market Pulse: Equities Rally Amid Mixed Big Tech Earnings; Economic Shifts and Sector-Specific Highlights New York, N.Y., April 26, 2024 - PRISM MarketView - Equities were higher through the morning into midday trading as the S&P 500 and Nasdaq are set to snap their three- and four-week losing streaks. Big tech was the topic of Street-talk this week as some of the Magnificent Seven reported earnings. The reports produced mixed and opposite reactions by the Street as Tesla (TSLA)...

SKYX Collaborates with World Leading Chinese Lighting Supplier and Manufacturer for the US, Chinese, and European Markets as it Continues to Enhance its Market Penetration

Apr 25, 2024

The Collaboration will Include SKYX’s Advanced and Smart Products to Both Professional and Retail Markets The Collaboration Agreement Provides SKYX Substantial Backing in Several Areas Including Financial, Mass Production Manufacturing Capabilities, and Distribution to Global Markets MIAMI, FL, April 25, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), (the "Company" or "SKYX"), a highly disruptive smart platform technology company with more than 90 issued and pending patents...

BioStem Technologies to Present at the 2024 Planet MicroCap Showcase

Apr 25, 2024

BioStem CEO, Jason Matuszewski, will present on Wednesday, May 1, 2024, at 11.30 am PST POMPANO BEACH, FLORIDA, April 25, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today announced that it will present at the Planet MicroCap Showcase: VEGAS 2024 held at the Paris Hotel & Casino, in Las Vegas, NV., from April 30 - May 2 2024....

SensaSure Technologies and Verde Bio Holdings Provide Update on Pending Merger

Apr 24, 2024

Registration Statement on Form S-4 Declared Effective by the Securities and Exchange Commission Special Meeting of SensaSure and Verde Stockholders to be held on May 9, 2024 Merger Expected to Close by the end of May 2024 LAS VEGAS, NV, April 24, 2024– SensaSure Technologies, Inc. (OTCQB: SSTC) (“SensaSure”) and Verde Bio Holdings, Inc. (OTC: VBHI) ("Verde" or the "Company"), a growing oil and gas company with a focus on the acquisition and management of oil and gas minerals and...

BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange

Apr 24, 2024

Strategic Audit Completion Set to Enhance BioStem Technologies' Market Position and Shareholder Value POMPANO BEACH, FLORIDA, April 24, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today announced the successful completion of comprehensive audits for fiscal years 2022 and 2023. This completion is a significant step in the company’s strategy to uplist to a...

PRISM MarketView – Biotech Breakfast

Apr 22, 2024

Roche’s Alecensa Gets FDA Green Light; ImmunityBio Gains as PDUFA Date Approaches for Bladder Cancer Drug; Key Drug Trial Failures in 2024 New York, N.Y., April 22, 2024 - PRISM MarketView - Healthcare equities finished mostly higher after a very quiet trading session on Friday. The S&P 500 Healthcare Index closed up +0.32% versus the S&P 500 Index which lost (0.88%) and the XBI settled down (0.78%). A lack of momentum today left Roche stock up by just +0.95% following the FDA greenlit...

PRISM MarketView – Weekly Market Report

Apr 19, 2024

PRISM Market Pulse: Market Tumbles Amid Fed's Rate Stance; Mixed Corporate Earnings Highlight Sector Struggles New York, N.Y., April 19, 2024 - PRISM MarketView - Equities were down in the morning and into midday as the major indices remain on track to notch their third straight week of declines. Fedspeak continues to support the “higher-for-longer” narrative with no urgency to cut rates which has created further sharp outflows and investor skepticism. The Street has taken investors’ pulses in...

PRISM MarketView – Bio Investor Alert

Apr 18, 2024

New York, N.Y., April 18, 2024 - PRISM MarketView - More than 83,000 new cases of bladder cancer are diagnosed in the US each year, and the illness is responsible for around 17,000 deaths annually. Urothelial carcinoma accounts for 90% of bladder cancers in the US and western Europe, and surgery, followed by chemotherapy or radiation is the current standard of care. There are 24 drugs approved by the FDA for bladder cancer, but due to invasive and life-changing surgical procedures, researchers...

Digital Utilities Ventures Completes Strategic Merger – Paving the Way for Future Growth and Innovation

Apr 18, 2024

Mankato, Minnesota, April 18, 2023 - Digital Utilities Ventures, Inc. (OTC: DUTV) is pleased to announce the successful completion of its acquisition of Easy Energy Systems Technologies, LLC and Easy Modular Manufacturing, Inc. The consummation of this transaction is a significant step forward in DUTV's mission to leverage disruptive modular technologies for addressing global challenges. Mark K. Gaalswyk, the visionary CEO behind this initiative, will lead the newly consolidated entity,...

TransGlobal Assets Inc. provides an update with the Joint-Venture partner Better Health Sciences For Pets Corp.

Apr 18, 2024

Cheyenne, WY, April 18, 2024 - TransGlobal Assets Inc. (OTC: TMSH) joint-venture partner, Better Health Sciences For Pets Corp., has taken a significant step by submitting two additional products to Health Canada for approval as Veterinary Health Products (VHPs). These products are currently awaiting their Notification Numbers (NNs) to be issued, indicating compliance with VHP regulations. This move highlights the commitment of TransGlobal Assets Inc., and Better Health Sciences For Pets...

American Shared Hospital Services Strengthens Senior Management Structure

Apr 18, 2024

SAN FRANCISCO, CA, April 18, 2024—American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announces changes to strengthen its senior management structure. AMS’ current Executive Chairman, Ray Stachowiak, will take on the role of Executive Chairman and Chief Executive Officer, and the Company’s President, Craig Tagawa, will become...

Status and Development of Oil and Gas industry Projects in Latin America

Apr 17, 2024

New York City, April 17, 2024 Status and Development of Oil and Gas Industry Projects in Latin America Get the free report Vostock Capital team has prepared a new report based on survey made during Colombia Oil and Gas 2023 Congress: Status and Projections 2024. We are pleased to share the results and analysis of our survey conducted on +200 attendees at the 2023 congress in Bogota: c- levels, government authorities, providers, and journalists. Hoping it will provide with deep insights into...

Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise

Apr 17, 2024

The new oncology committee will include: Jason Hafron, MD, DDS, PhD, MPH; and Pradeep Tyagi, PhD, MBA Pittsburgh, PA, April 17, 2024 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company, today announced the expansion of its Scientific Advisory Board to include oncology expertise. The new committee members are: Jason Hafron, MD, DDS, PhD, MPH, the Chief Medical Officer at Michigan Institute of Urology, and Professor of Urology at the...

Vocodia Holdings Corp Delivers a Corporate Update on Strategic Growth

Apr 17, 2024

Company outlines vision for building long-term shareholder growth Boca Raton, April 17, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), a leader in AI software development focusing on practical AI applications, today provided an update on the Company's progress since becoming public, highlighting recent achievements and outlining future growth strategies. Brian Podolak, CEO of Vocodia, expressed optimism about the Company’s trajectory, stating, “Vocodia is...

PRISM MarketView – Biotech Breakfast

Apr 15, 2024

Mobile-Health Network Solutions (MNDR) IPOs; Q32 Bio Surges; EMA Concludes GLP-1 Drugs Not Associated with Suicidal Thoughts New York, N.Y., April 15, 2024 - PRISM MarketView - Healthcare equities finished lower on Friday, in line with broad declines across the market. The S&P 500 Healthcare Index closed down (1.52%) versus the S&P 500 Index which lost (1.46%) and the XBI settled down (3.43%). The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee concluded...

American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione

Apr 12, 2024

SAN FRANCISCO, CA, April 12, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announces the sudden passing of its Chief Executive Officer, Peter Gaccione. Ray Stachowiak, Executive Chairman of American Shared Hospital Services, said, “On behalf of my colleagues at AMS, we are deeply saddened by the unexpected passing of...

ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS

Apr 12, 2024

Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, April 12, 2024 - Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the year ended December 31, 2023. Recent Highlights Bio-Rad Laboratories, Inc. commercial partnership for transplant monitoring IP $15.8 million in gross proceeds received from private placement offering $4.4 million and $3.8 million Q4 2023 and est. Q1 2024 cash burn, respectively...

NEWSROOM

PRISM MarketView

Categories

Tags